Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday.

A number of other research analysts also recently weighed in on GRDN. Truist Financial raised their price objective on Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Oppenheimer started coverage on Guardian Pharmacy Services in a research note on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective on the stock. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Guardian Pharmacy Services in a research note on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $29.33.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock opened at $28.16 on Friday. The stock’s 50 day simple moving average is $26.51 and its 200 day simple moving average is $23.71. Guardian Pharmacy Services has a twelve month low of $17.29 and a twelve month high of $30.39. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of -18.53 and a beta of 0.96.

Institutional Trading of Guardian Pharmacy Services

Several institutional investors have recently modified their holdings of the company. Brown Advisory Inc. grew its holdings in shares of Guardian Pharmacy Services by 5.0% during the 2nd quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after purchasing an additional 79,652 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Guardian Pharmacy Services by 32.2% during the 2nd quarter. Franklin Resources Inc. now owns 976,207 shares of the company’s stock worth $20,803,000 after purchasing an additional 237,630 shares in the last quarter. TimesSquare Capital Management LLC acquired a new stake in shares of Guardian Pharmacy Services during the 2nd quarter worth approximately $17,351,000. Wellington Management Group LLP grew its holdings in shares of Guardian Pharmacy Services by 14.2% during the 1st quarter. Wellington Management Group LLP now owns 464,924 shares of the company’s stock worth $9,884,000 after purchasing an additional 57,924 shares in the last quarter. Finally, Woodline Partners LP grew its holdings in shares of Guardian Pharmacy Services by 1.5% during the 1st quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock worth $8,955,000 after purchasing an additional 6,083 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.